Cite
HARVARD Citation
Delgado, J. et al. (2021). The European Medicines Agency Review of Tafasitamab in Combination With Lenalidomide for the Treatment of Adult Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma. HemaSphere. 5 (12), pp. e666-. [Online].